Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02034981 |
|---|---|
| Brief Title: | Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 (AcSé) |
| First Submitted : | October 16, 2013 |
| First Submitted that Met QC Criteria : | January 10, 2014 |
| First Posted : | January 14, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 26, 2024 |
| Last Update Posted : | February 28, 2024 |